In this episode, Elizabeth chats with Kate Cameron, CEO of Cytochroma, the biotech company creating mini hearts and livers from genetically diverse stem cells. Kate explains how these mini organs could transform drug testing by replacing animal models and providing more accurate, inclusive data. She also reflects on her transition from scientist to founder, sharing how she’s learned to embrace the business side of innovation.